Actively Recruiting
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Led by Massachusetts General Hospital · Updated on 2025-11-18
400
Participants Needed
3
Research Sites
234 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Many people living with metastatic breast cancer face challenging symptoms and frequent medical visits. At the same time, conversations about personal goals, values, and preferences for care may not always happen as early or as often as patients and families would like. This multi-site study will test the effectiveness of a five-session palliative care program, designed specifically for people with metastatic breast cancer and their caregivers, to strengthen communication with clinicians about what matters most in their care. The study aims to inform how palliative care services can be delivered in a more timely, personalized, and scalable way for people living with advanced cancers who have long disease trajectories, such as metastatic breast cancer.
CONDITIONS
Official Title
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosed with metastatic breast cancer
- Within 8 weeks of the oncology visit at which they were identified as having an eligible Epic EOL Care Index (≥ 15)
- Functioning independently with an Eastern Cooperative Oncology Group performance status of 2 or less
- Receiving cancer care at one of the participating institutions
- Able to complete questionnaires in English or Spanish
- Caregivers must be 18 years or older
- Caregivers identified by the patient as a family member or friend primarily involved in their care
- Caregivers able to complete questionnaires in English or Spanish
You will not qualify if you...
- Received outpatient palliative care visit within the last six months
- Enrolled in hospice services
- Diagnosed with a comorbid condition that impairs ability to understand study procedures or consent, as reported by oncology clinicians
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02465
Actively Recruiting
2
Duke University
Durham, North Carolina, United States, 54677
Actively Recruiting
3
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 46205
Actively Recruiting
Research Team
J
Jennifer Temel, MD
CONTACT
J
Joseph Greer, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here